Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Effectiveness of systemic voriconazole in reducing post-surgical recurrence of aspergillus mycotic rhinosinusitis.

View through CrossRef
Objective: To determine voriconazole efficacy in postoperative FESS patients to prevent or minimize recurrence of Aspergillus associated rhinosinusitis. Study Design: Observational Prospective Analytical. Setting: Department of ENT and Head & Neck Surgery, KRL Hospital Islamabad. Period: 01.07.2021 to 30.06.2022. Methods: 57 patients (selected by simple random sampling technique) who underwent FESS for mycotic disease caused by Aspergillus species were followed prospectively as per the department’s follow up protocols while receiving post-operative voriconazole. The initial dose and duration of oral drug advised depended on the severity and extent of disease at the time of surgery and the dose was adjusted on subsequent OPD reviews based on endoscopic nasal examination findings, visual analogue score for total nasal sinus symptoms as well as radiological findings where necessary. The success of treatment was monitored to check the efficacy of voriconazole in preventing post-surgical recurrence and the importance of response-based dose adjustments in patients suffering from mycotic rhinosinusitis. Data analysis was done using SPSS version 20. Results: Among 57 patients (mean age 32 years), systemic voriconazole after FESS showed high efficacy, with 89.5% remaining relapse-free at one year. Only six patients (10.5%) developed recurrence, mostly after tapering therapy, and three (5.3%) discontinued treatment due to adverse effects or noncompliance. Serial VAS, CT, and endoscopy scores demonstrated progressive improvement, with 35.1% achieving complete recovery by 12 weeks. Conclusion: We would like to conclude that voriconazole has proven highly effective in the treatment of sinonasal aspergillosis and has been proven to be the drug of choice to compliment thorough surgical clearance. Re-administration of voriconazole may be warranted at the slightest hint of recurrence noted on nasal endoscopic or radiological examination which may need to be biopsy proven.
Title: Effectiveness of systemic voriconazole in reducing post-surgical recurrence of aspergillus mycotic rhinosinusitis.
Description:
Objective: To determine voriconazole efficacy in postoperative FESS patients to prevent or minimize recurrence of Aspergillus associated rhinosinusitis.
Study Design: Observational Prospective Analytical.
Setting: Department of ENT and Head & Neck Surgery, KRL Hospital Islamabad.
Period: 01.
07.
2021 to 30.
06.
2022.
Methods: 57 patients (selected by simple random sampling technique) who underwent FESS for mycotic disease caused by Aspergillus species were followed prospectively as per the department’s follow up protocols while receiving post-operative voriconazole.
The initial dose and duration of oral drug advised depended on the severity and extent of disease at the time of surgery and the dose was adjusted on subsequent OPD reviews based on endoscopic nasal examination findings, visual analogue score for total nasal sinus symptoms as well as radiological findings where necessary.
The success of treatment was monitored to check the efficacy of voriconazole in preventing post-surgical recurrence and the importance of response-based dose adjustments in patients suffering from mycotic rhinosinusitis.
Data analysis was done using SPSS version 20.
Results: Among 57 patients (mean age 32 years), systemic voriconazole after FESS showed high efficacy, with 89.
5% remaining relapse-free at one year.
Only six patients (10.
5%) developed recurrence, mostly after tapering therapy, and three (5.
3%) discontinued treatment due to adverse effects or noncompliance.
Serial VAS, CT, and endoscopy scores demonstrated progressive improvement, with 35.
1% achieving complete recovery by 12 weeks.
Conclusion: We would like to conclude that voriconazole has proven highly effective in the treatment of sinonasal aspergillosis and has been proven to be the drug of choice to compliment thorough surgical clearance.
Re-administration of voriconazole may be warranted at the slightest hint of recurrence noted on nasal endoscopic or radiological examination which may need to be biopsy proven.

Related Results

Hydatid Disease of The Brain Parenchyma: A Systematic Review
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Abstarct Introduction Isolated brain hydatid disease (BHD) is an extremely rare form of echinococcosis. A prompt and timely diagnosis is a crucial step in disease management. This ...
A reappraisal of measured voriconazole concentration based on plasma albumin concentration during therapeutic drug monitoring
A reappraisal of measured voriconazole concentration based on plasma albumin concentration during therapeutic drug monitoring
Background: The unbound fraction of voriconazole can be elevated due to a decreased plasma albumin concentration. Given its nonlinear pharmacokinetic profile, this elevation can ca...
Effects of inflammation on voriconazole metabolism and peripheral blood trough concentration
Effects of inflammation on voriconazole metabolism and peripheral blood trough concentration
Abstract Background The inner association of inflammation with voriconazole (VCZ) metabolism has not been fully investigated. This study further discussed the relationship...
Pharmacokinetic interactions of efavirenz and voriconazole in healthy volunteers
Pharmacokinetic interactions of efavirenz and voriconazole in healthy volunteers
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • Efavirenz 400 mg q24 h reduces exposure to voriconazole 200 mg q12 h when the two drugs are co‐administered.• Furthermore, voriconazole i...
S1.5b The burden of mycotic keratitis in West Africa
S1.5b The burden of mycotic keratitis in West Africa
Abstract S1.5 Mycotic keratitis, September 21, 2022, 11:00 AM - 12:30 PM   Bac...
Proporsi karakteristik penderita rinosinusitis kronis dengan kultur jamur positif
Proporsi karakteristik penderita rinosinusitis kronis dengan kultur jamur positif
Latar belakang: Rinosinusitis dengan infeksi jamur atau disebut juga rinosinusitis jamur adalahinflamasi mukosa sinus paranasal yang disebabkan oleh infeksi jamur. Gejala klinik ri...
Atypical Presentations of Pilonidal Sinus Disease: A Case Series with Literature Review
Atypical Presentations of Pilonidal Sinus Disease: A Case Series with Literature Review
Abstract Introduction: Pilonidal sinus (PNS) typically arises in the sacrococcygeal region but can occasionally present in atypical locations, including the axilla, intermammary re...
Giant Sacrococcygeal Teratoma in Infant: Systematic Review
Giant Sacrococcygeal Teratoma in Infant: Systematic Review
Abstract Introduction Sacrococcygeal teratoma (SCT) is a rare embryonal tumor that occurs in the sacrococcygeal region, with an incidence of about 1 in 35,000 to 40,000 live births...

Back to Top